Genmab shares hit record high as U.S. widens use of cancer drug
COPENHAGEN, Nov 22 (Reuters) - Shares in Danish biotech company Genmab jumped to a record high on Tuesday after U.S. regulators approved widening the use its blood cancer drug Darzalex, prompting the... [Source]
Publication Date:Origin: reuters.com
Category: hotStocksNews
Topics: cancer, record, Genmab, prompting, drug Darzalex, blood, widening, approved, regulators, after U, jumped, biotech company, Danish, Shares, (Reuters), COPENHAGEN, widens, shares
Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/LN8KR1_KTUE/genmab-stocks-idUSL8N1DN1WC